The Max Foundation shared a post on LinkedIn:
“We’re proud to recognize BeOne Medicines as a valued partner and sponsor of our Global Impact Celebration.
Through our partnership, BeOne Medicines, together with the BeOne Care Foundation, has helped support 293 people living with Chronic Lymphocytic Leukemia (CLL) across Armenia, Nepal, and Ethiopia access transformational medicines.
This work represents more than numbers. It reflects care reaching people, families finding hope, and health systems growing stronger through collaboration.
Thank you for helping ensure that geography does not determine a person’s chance to survive cancer.”
Other articles featuring The Max Foundation on OncoDaily.